Insider · CIK 0001968528
Kevin K Buckbee
officer
Files at ABBV (AbbVie Inc.). First filing Dec 18, 2024, latest Feb 28, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $4.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ABBV: AbbVie Inc.
ABBVOct 9, 2026 · close 276.47
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 70Notable | AbbVie Inc. | $3.9M 18,944 shares | -124% | +24% from low-1% from high | |
| 19Weak | ABBVsell AbbVie Inc. | $310k 1,800 shares | -20% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | ABBV AbbVie Inc. | FTax withholding Common Stock, $0.01 par value | -3,699 | $205.02 | $758k | 7,797 | Mar 4, 2025 |
| Feb 26, 2025 | ABBV AbbVie Inc. | SOpen-market sale Common Stock, $0.01 par value | -2,684 | $203.40 | $546k | 12,646 | Feb 28, 2025 |
| Feb 26, 2025 | ABBV AbbVie Inc. | MOption exercise Common Stock, $0.01 par value | +9,738 | $93.50 | $911k | 22,384 | Feb 28, 2025 |
| Feb 26, 2025 | ABBV AbbVie Inc. | MOption exercise Common Stock, $0.01 par value | +6,522 | $105.92 | $691k | 28,906 | Feb 28, 2025 |
| Feb 26, 2025 | ABBV AbbVie Inc. | SOpen-market sale Common Stock, $0.01 par value | -16,260 | $203.41 | $3.3M | 11,496 | Feb 28, 2025 |
| Feb 26, 2025 | ABBV AbbVie Inc. | MOption exercise Option (Right to buy)derivative | -9,738 | $93.50 | $911k | 2,373 | Feb 28, 2025 |
| Feb 26, 2025 | ABBV AbbVie Inc. | MOption exercise Option (Right to buy)derivative | -6,522 | $105.92 | $691k | 2,794 | Feb 28, 2025 |
| Feb 13, 2025 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +3,595 | $0.00 | $0 | 10,578 | Feb 18, 2025 |
| Feb 13, 2025 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +1,474 | $0.00 | $0 | 12,052 | Feb 18, 2025 |
| Feb 13, 2025 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +1,604 | $0.00 | $0 | 13,656 | Feb 18, 2025 |
| Feb 13, 2025 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +1,674 | $0.00 | $0 | 15,330 | Feb 18, 2025 |
| Feb 13, 2025 | ABBV AbbVie Inc. | AGrant or award Option (Right to buy)derivative | +6,250 | $0.00 | $0 | 6,250 | Feb 18, 2025 |
| Dec 16, 2024 | ABBV AbbVie Inc. | MOption exercise Common Stock, $0.01 par value | +1,800 | $93.50 | $168k | 8,783 | Dec 18, 2024 |
| Dec 16, 2024 | ABBV AbbVie Inc. | SOpen-market sale Common Stock, $0.01 par value | -1,800 | $172.24 | $310k | 6,983 | Dec 18, 2024 |
| Dec 16, 2024 | ABBV AbbVie Inc. | MOption exercise Option (Right to buy)derivative | -1,800 | $93.50 | $168k | 12,111 | Dec 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.